Bausch Health Companies Operating Expenses Growth & History (BHC)
Bausch Health Companies's operating expenses was $8.45B for fiscal 2025.
View full Bausch Health Companies company overviewBausch Health Companies annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.45B | $374.0M | +4.63% |
| 2024 | 2024-12-31 | $8.08B | $285.0M | +3.66% |
| 2023 | 2023-12-31 | $7.79B | $124.0M | +1.62% |
| 2022 | 2022-12-31 | $7.67B | −$314.0M | −3.93% |
| 2021 | 2021-12-31 | $7.98B | $633.0M | +8.61% |
| 2020 | 2020-12-31 | $7.35B | −$1.45B | −16.50% |
| 2019 | 2019-12-31 | $8.80B | −$1.96B | −18.21% |
| 2018 | 2018-12-31 | $10.76B | $2.14B | +24.84% |
| 2017 | 2017-12-31 | $8.62B | −$1.62B | −15.80% |
| 2016 | 2016-12-31 | $10.24B | $1.32B | +14.80% |
| 2015 | 2015-12-31 | $8.92B | $2.71B | +43.76% |
| 2014 | 2014-12-31 | $6.21B | $25.9M | +0.42% |
| 2013 | 2013-12-31 | $6.18B | $2.78B | +81.70% |
| 2012 | 2012-12-31 | $3.40B | $1.27B | +59.85% |
| 2011 | 2011-12-31 | $2.13B | $836.2M | +64.75% |
| 2010 | 2010-12-31 | $1.29B | $652.0M | +102.00% |
| 2009 | 2009-12-31 | $639.3M | $6.2M | +0.98% |
| 2008 | 2008-12-31 | $633.1M | — | — |
Bausch Health Companies quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.11B | $26.0M | +1.25% |
| Q1 2026 | 2026-03-31 | $3.47B | $1.49B | +75.19% |
| Q4 2025 | 2025-12-31 | $2.32B | $321.0M | +16.04% |
| Q3 2025 | 2025-09-30 | $2.06B | −$130.0M | −5.93% |
| Q2 2025 | 2025-06-30 | $2.09B | $72.0M | +3.57% |
| Q1 2025 | 2025-03-31 | $1.98B | $111.0M | +5.93% |
| Q4 2024 | 2024-12-31 | $2.00B | −$45.0M | −2.20% |
| Q3 2024 | 2024-09-30 | $2.19B | −$32.0M | −1.44% |
| Q2 2024 | 2024-06-30 | $2.01B | $259.0M | +14.76% |
| Q1 2024 | 2024-03-31 | $1.87B | $103.0M | +5.82% |
| Q4 2023 | 2023-12-31 | $2.05B | −$383.0M | −15.77% |
| Q3 2023 | 2023-09-30 | $2.22B | $422.0M | +23.42% |
| Q2 2023 | 2023-06-30 | $1.75B | −$51.0M | −2.82% |
| Q1 2023 | 2023-03-31 | $1.77B | $136.0M | +8.33% |
| Q4 2022 | 2022-12-31 | $2.43B | $600.0M | +32.80% |
| Q3 2022 | 2022-09-30 | $1.80B | $265.0M | +17.24% |
| Q2 2022 | 2022-06-30 | $1.81B | −$564.0M | −23.80% |
| Q1 2022 | 2022-03-31 | $1.63B | −$615.0M | −27.36% |
| Q4 2021 | 2021-12-31 | $1.83B | −$389.0M | −17.54% |
| Q3 2021 | 2021-09-30 | $1.54B | −$141.0M | −8.40% |
| Q2 2021 | 2021-06-30 | $2.37B | $679.0M | +40.15% |
| Q1 2021 | 2021-03-31 | $2.25B | $484.0M | +27.44% |
| Q4 2020 | 2020-12-31 | $2.22B | −$1.08B | −32.79% |
| Q3 2020 | 2020-09-30 | $1.68B | −$202.0M | −10.74% |
| Q2 2020 | 2020-06-30 | $1.69B | −$204.0M | −10.77% |
| Q1 2020 | 2020-03-31 | $1.76B | $35.0M | +2.02% |
| Q4 2019 | 2019-12-31 | $3.30B | $1.20B | +57.44% |
| Q3 2019 | 2019-09-30 | $1.88B | −$139.0M | −6.88% |
| Q2 2019 | 2019-06-30 | $1.90B | −$478.0M | −20.14% |
| Q1 2019 | 2019-03-31 | $1.73B | −$2.55B | −59.57% |
| Q4 2018 | 2018-12-31 | $2.10B | −$389.0M | −15.65% |
| Q3 2018 | 2018-09-30 | $2.02B | −$162.0M | −7.43% |
| Q2 2018 | 2018-06-30 | $2.37B | $315.0M | +15.31% |
| Q1 2018 | 2018-03-31 | $4.28B | $2.38B | +125.29% |
| Q4 2017 | 2017-12-31 | $2.48B | $232.0M | +10.30% |
| Q3 2017 | 2017-09-30 | $2.18B | −$1.16B | −34.74% |
| Q2 2017 | 2017-06-30 | $2.06B | −$281.0M | −12.01% |
| Q1 2017 | 2017-03-31 | $1.90B | −$408.0M | −17.69% |
| Q4 2016 | 2016-12-31 | $2.25B | −$337.0M | −13.01% |
| Q3 2016 | 2016-09-30 | $3.34B | $1.00B | +42.88% |
| Q2 2016 | 2016-06-30 | $2.34B | −$52.0M | −2.17% |
| Q1 2016 | 2016-03-31 | $2.31B | $706.0M | +44.13% |
| Q4 2015 | 2015-12-31 | $2.59B | $972.0M | +60.07% |
| Q3 2015 | 2015-09-30 | $2.34B | $967.3M | +70.52% |
| Q2 2015 | 2015-06-30 | $2.39B | $705.0M | +41.81% |
| Q1 2015 | 2015-03-31 | $1.60B | $70.4M | +4.60% |
| Q4 2014 | 2014-12-31 | $1.62B | −$222.3M | −12.08% |
| Q3 2014 | 2014-09-30 | $1.37B | −$1.06B | −43.63% |
| Q2 2014 | 2014-06-30 | $1.69B | $731.8M | +76.69% |
| Q1 2014 | 2014-03-31 | $1.53B | $578.2M | +60.77% |
| Q4 2013 | 2013-12-31 | $1.84B | $822.2M | +80.75% |
| Q3 2013 | 2013-09-30 | $2.43B | $1.58B | +184.69% |
| Q2 2013 | 2013-06-30 | $954.2M | $220.9M | +30.13% |
| Q1 2013 | 2013-03-31 | $951.4M | $156.8M | +19.73% |
| Q4 2012 | 2012-12-31 | $1.02B | $360.1M | +54.72% |
| Q3 2012 | 2012-09-30 | $854.7M | $366.4M | +75.06% |
| Q2 2012 | 2012-06-30 | $733.3M | $242.4M | +49.37% |
| Q1 2012 | 2012-03-31 | $794.6M | $304.3M | +62.07% |
| Q4 2011 | 2011-12-31 | $658.1M | $94.5M | +16.78% |
| Q3 2011 | 2011-09-30 | $488.2M | $153.6M | +45.92% |
| Q2 2011 | 2011-06-30 | $490.9M | $301.0M | +158.44% |
| Q1 2011 | 2011-03-31 | $490.3M | $287.0M | +141.20% |
| Q4 2010 | 2010-12-31 | $563.5M | — | — |
| Q3 2010 | 2010-09-30 | $334.6M | $180.4M | +117.01% |
| Q2 2010 | 2010-06-30 | $190.0M | $7.0M | +3.81% |
| Q1 2010 | 2010-03-31 | $203.3M | — | — |
| Q3 2009 | 2009-09-30 | $154.2M | — | — |
| Q2 2009 | 2009-06-30 | $183.0M | — | — |
Bausch Health Companies operating expenses trends
Over the last five fiscal years, Bausch Health Companies's operating expenses increased from $7.35B to $8.45B, a change of $1.10B. The latest reported quarter, Q2 2026, shows $2.11B.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bausch Health Companies source filings ↗